Target intelligence / Profile preview

Salmonella flagellin protein (FliC) (FliC)

Target
FliC
Molecular classification
Bacterial protein, Toll-like receptor 5 (TLR5) agonist, Adjuvant
01

Overview

Salmonella flagellin is the primary structural protein of the bacterial flagellum, typically encoded by the fliC or fljB genes in Salmonella species. It functions as a potent pathogen-associated molecular pattern (PAMP) that is specifically recognized by the host's Toll-like receptor 5 (TLR5), triggering the activation of the NF-kappaB signaling pathway and the subsequent production of pro-inflammatory cytokines and anti-apoptotic proteins (UniProt Consortium, 2023; Leigh et al., 2014). In therapeutic development, flagellin-derived molecules such as Entolimod (CBLB502) are utilized as TLR5 agonists to protect healthy tissues from radiation-induced damage and to stimulate anti-tumor immune responses (Burdelya et al., 2008). Additionally, flagellin is widely used as a vaccine adjuvant due to its ability to enhance the immunogenicity of co-administered antigens by activating dendritic cells and promoting a robust adaptive immune response (Huleatt et al., 2008). Despite its therapeutic potential, challenges include the risk of systemic inflammatory side effects, such as cytokine release syndrome, and the potential for the development of neutralizing anti-flagellin antibodies that may limit the efficacy of repeated administrations (Kandimalla et al., 2007).

Other names
FlagellinFliCFljBH-antigenTLR5 ligandPhase 1 flagellin
02

Mechanism of action

Agonism of Toll-like receptor 5 (TLR5) leading to the activation of NF-kappaB and AP-1 signaling pathways, which induces the expression of protective cytokines and anti-apoptotic factors (Burdelya et al., 2008; Leigh et al., 2014).

03

Biological functions

Bacterial motilityInnate immune response activationNF-kappaB signaling pathway activationPro-inflammatory cytokine productionApoptosis inhibition
04

Disease associations

Infection (Salmonellosis)CancerAcute Radiation SyndromeInflammatory bowel disease
05

Safety considerations

Systemic inflammatory response syndromePotential for cytokine stormDevelopment of neutralizing anti-drug antibodies (ADAs)Transient elevation of liver enzymesInjection site reactions
06

Interacting drugs

Entolimod (CBLB502)

4 more in the full profile.

07

Biomarkers

Serum Interleukin-6 (IL-6)Granulocyte colony-stimulating factor (G-CSF)TLR5 expression levelsAnti-flagellin antibody titers

Beyond the preview

Go deeper on Salmonella flagellin protein (FliC) (FliC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella flagellin protein (FliC) (FliC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call